GENE ONLINE|News &
Opinion
Blog

Biogen
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
JPM 2024: Biotech Companies Mapping Out Their Future, and a New Round of M&A Spree Begins
2024-01-09
GeneOnline’s Weekly News Highlights: July 24-28
2023-08-01
FDA Granted Eisai and Biogen’s New Alzheimer’s Drug a Traditional Approval, Making Medicare Coverage Possible
2023-07-11
GeneOnline’s Weekly News Highlights: July 3-7
2023-07-10
FDA Grants Biogen’s Ultra-Rare ALS Med Accelerated Approval
2023-04-26
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
2023-03-21
Genentech Takes Biogen to Court Over Stockpiled Multiple Sclerosis Drug Royalties
2023-03-01
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
Eisai and Biogen’s Alzheimer’s Med, Leqembi, Granted FDA Approval
2023-01-09
The FDA and Biogen Taking Heat for Aduhelm’s Approval Process
2022-12-30
Biogen To Receive Potential Royalties For Anti-CD20 Bispecific From Genentech
2022-12-20
FDA Pushes Biogen’s ALS Drug Approval Date Back Three Months
2022-10-18
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Alectos Promised $722 Million in Parkinson’s Collab With Biogen
2022-06-07
1 2 3 4
LATEST
Merck’s KEYNOTE-522 Success; BMS Licenses PRX019, Prothena Gets $80M
2024-06-19
Pie Medical Imaging announces enrollment completion of the FASTIII clinical trial
2024-06-18
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
EVENT
Scroll to Top